To ask the Secretary of State for Health, if he will take steps to ensure that the FreeStyle Libre Flash Glucose Monitoring system is accessible to all diabetes patients
1 December 2017
Freestyle Libre has been approved for reimbursement on National Health Service prescription from 1 November through listing in Part IX of the Drug Tariff. The Drug Tariff is a price list that covers England and Wales, and the listing of a medical device in the Tariff should not be interpreted as a recommendation to prescribe a particular product. Patients will need to discuss the ongoing management of their condition with their healthcare professional and consider whether flash glucose monitoring is suitable for them.